MENS

+ Watchlist + Portfolio

Jyong Biotech Ltd.

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $2.03
52-Week Range: $1.43 – $63.00
Market Cap: $165.74M
P/E (TTM): —
EPS (TTM): -0.06
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: —
PEG Ratio: —
Return on Equity: —
Return on Assets: -12.01%
Gross Margin: 0.00%
Operating Margin: 0.00%
Profit Margin: 0.00%
Current Ratio: 0.45
Debt/Equity: —
Total Debt: $18.55M
Free Cash Flow: $4.39M
Revenue Growth: —
Earnings Growth: —
Enterprise Value: $179.20M

MENS Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$0.00	$0.00	$0.00	$0.00
Research & Development	$1.29M	$1.07M	$927.00K	$813.00K
Selling, General & Admin	$1.54M	$1.73M	$1.13M	$1.79M
Operating Expenses	$2.83M	$2.80M	$2.06M	$2.61M
Operating Income	-$2.83M	-$2.80M	-$2.06M	-$2.61M
EBITDA	-$5.74M	-$3.52M	-$1.86M	-$2.03M
Pretax Income	-$6.63M	-$4.40M	-$3.02M	-$4.67M
Income Tax	$0.00	$0.00	$0.00	$0.00
Net Income	-$6.63M	-$4.40M	-$3.02M	-$4.67M
Diluted EPS	-0.09	-0.06	-0.04	—
Diluted Shares	76.03M	76.03M	76.03M	—

MENS Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$718.00K	$177.00K	$98.00K	$1.18M
Receivables	—	—	$0.00	$13.51M
Current Assets	$2.46M	$1.84M	$206.00K	$15.54M
Total Assets	$8.74M	$8.25M	$6.37M	$20.78M
Current Liabilities	$12.91M	$14.26M	$12.13M	$34.81M
Long-Term Debt	$6.32M	$8.52M	$10.68M	$10.16M
Total Debt	$14.25M	$16.69M	$18.14M	$18.55M
Total Liabilities	$38.38M	$42.32M	$42.88M	$45.68M
Retained Earnings	-$25.66M	-$30.06M	-$33.08M	-$37.75M
Shareholders' Equity	-$29.63M	-$34.07M	-$36.52M	-$24.91M
Working Capital	-$10.44M	-$12.42M	-$11.92M	-$19.27M
Net Debt	$13.25M	$16.32M	$17.86M	$17.27M

MENS Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$2.97M	-$2.60M	-$3.62M	-$3.04M
Capital Expenditure	-$246.00K	—	—	—
Free Cash Flow	-$3.22M	-$2.60M	-$3.62M	-$3.04M
Depreciation & Amortisation	$123.00K	$127.00K	$120.00K	$100.00K
Investing Cash Flow	$1.39M	$95.00K	$0.00	-$13.51M
Financing Cash Flow	$3.33M	$2.03M	$1.99M	$17.63M
Net Change in Cash	$1.75M	-$478.00K	-$1.63M	$1.08M

MENS Balance Sheet statement, quarterly periods, in USD
USD	Q4 2024	Q2 2025	Q4 2025
Cash & Equivalents	$98.00K	$132.00K	$1.18M
Receivables	$0.00	—	$13.51M
Current Assets	$206.00K	$17.16M	$15.54M
Total Assets	$6.37M	$37.67M	$20.78M
Current Liabilities	$12.13M	$27.55M	$34.81M
Long-Term Debt	$10.68M	$12.27M	$10.16M
Total Debt	$18.14M	$35.19M	$18.55M
Total Liabilities	$42.88M	$60.14M	$45.68M
Retained Earnings	-$33.08M	-$34.33M	-$37.75M
Shareholders' Equity	-$36.52M	-$22.47M	-$24.91M
Working Capital	-$11.92M	-$10.39M	-$19.27M
Net Debt	$17.86M	$34.92M	$17.27M

Market Snapshot

About

Jyong Biotech Ltd. is a biotechnology company focused on developing therapeutic solutions and diagnostic products. The company engages in research and development activities targeting various disease areas. Jyong Biotech operates in the pharmaceutical and biotech sector with a focus on innovative medical technologies.